|
Charles River Laboratories International Inc - Comparative Business Analysis Snapshot
Business Description
Charles River Laboratories International Inc. The Group's principal activity is providing solutions that accelerate the drug discovery and development process. It partners with global pharmaceutical and biotechnology companies, government agencies and academic institutions worldwide in order to bring drugs to market faster and more efficiently. The Group currently operates approximately 70 facilities in 15 countries worldwide. Its activities are carried out through two segments: Preclinical Services (PCS) and Research Models and Services (RMS). PCS includes development services which enable customers to accelerate their drug discovery and development process. RMS includes its research model business, research model services, vaccine support services and in vitro technology services. The Group has operations in the United States, Canada, Scotland, Ireland, United Kingdom, France, Germany, Japan and Mexico.
Competitor Analysis
This analysis compares Charles River Laboratories International Inc with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
